Marathon Trading Investment Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-17,880
Closed -$441K 340
2025
Q2
$433K Buy
+17,880
New +$417K 0.05% 142
2025
Q1
Sell
-1,399
Closed -$36.6K 404
2024
Q4
$37.1K Sell
1,399
-9,218
-87% -$250K ﹤0.01% 274
2024
Q3
$307K Sell
10,617
-4,354
-29% -$127K 0.03% 181
2024
Q2
$419K Sell
14,971
-26,838
-64% -$739K 0.03% 151
2024
Q1
$1.16M Sell
41,809
-125,089
-75% -$3.47M 0.09% 110
2023
Q4
$4.8M Buy
166,898
+90,257
+118% +$2.73M 0.24% 60
2023
Q3
$2.54M Buy
76,641
+59,121
+337% +$2.09M 0.21% 64
2023
Q2
$643K Buy
17,520
+5,607
+47% +$218K 0.05% 119
2023
Q1
$486K Buy
11,913
+7,513
+171% +$324K 0.04% 135
2022
Q4
$225K Sell
4,400
-5,012
-53% -$240K 0.03% 178
2022
Q3
$412K Buy
9,412
+5,012
+114% +$244K 0.04% 167
2022
Q2
$231K Hold
4,400
0.03% 210
2022
Q1
$228K Buy
+4,400
New +$228K 0.02% 241
2021
Q2
Sell
-6,800
Closed -$246K 368
2021
Q1
$246K Sell
6,800
-5,100
-43% -$181K 0.02% 303
2020
Q4
$438K Buy
+11,900
New +$436K 0.02% 239
2015
Q4
Sell
-8,550
Closed -$255K 279
2015
Q3
$255K Hold
8,550
0.01% 264
2015
Q2
$272K Hold
8,550
0.01% 389
2015
Q1
$282K Buy
+8,550
New +$272K 0.01% 398
2013
Q3
Sell
-59,668
Closed -$1.59M 170
2013
Q2
$1.59M Buy
+59,668
New +$1.65M 0.11% 58

Other funds holding PFE

Marathon Trading Investment Management's PFE Position: Q3 2025 in Review

Marathon Trading Investment Management sold out of Pfizer (PFE) in Q3 2025, closing a stake of 17,880 shares — an estimated $441K sold.

Marathon Trading Investment Management first reported a position in PFE in Q2 2013 and held it in 19 quarters. The position peaked at $4.8M in Q4 2023. 2,811 funds tracked by Wall St. Rank hold PFE as of Q3 2025.

  • Marathon Trading Investment Management reported no remaining Pfizer position as of Q3 2025 after selling out during the quarter.
  • Marathon Trading Investment Management sold 17,880 Pfizer shares in Q3 2025, an estimated $441K.
  • Marathon Trading Investment Management first reported a position in Pfizer in Q2 2013 and held it in 19 quarters.
  • Marathon Trading Investment Management's Pfizer position peaked at $4.8M in Q4 2023.
  • 2,811 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.

Based on Marathon Trading Investment Management's 13F filing for Q3 2025, filed 13 Nov 2025.